Gene · 1512
Papers1,642
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,642
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Atypical Presentation of Exertional Rhabdomyolysis in Older Adults: Two Case Reports and Literature Review. | Am J Case Rep | 2026 | 41630384 | PubTator, text mining | PubMed |
| Urinary proteomic biomarkers of systemic fluoride exposure in children. | Ecotoxicol Environ Saf | 2026 | 41601072 | PubTator, text mining | PubMed |
| Cathepsins E, O, and S: Novel Biomarkers and Therapeutic Targets in Breast Carcinoma. | Curr Med Chem | 2026 | 41582589 | PubTator, text mining | PubMed |
| Prosaposin Is Cleaved Into Saposins by Multiple Cathepsins in a Progranulin-Regulated Fashion. | J Neurochem | 2026 | 41572567 | PubTator, text mining | PubMed |
| Novel treatment strategies for cardiovascular and pulmonary diseases: Insights from cathepsin-related Mendelian randomization and Bayesian colocalization. | Medicine (Baltimore) | 2026 | 41496066 | PubTator, text mining | PubMed |
| Druggable targets and immunological mechanisms for type 1 diabetes treatment: Genetic evidence from multi-omics Mendelian randomization combined with meta-analysis. | Diabet Med | 2026 | 41423778 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine derivatives as cathepsin L inhibitor for the treatment of acute lung injury. | Eur J Med Chem | 2026 | 41389412 | PubTator, text mining | PubMed |
| Microglial phagocytosis in Alzheimer disease. | Nat Rev Neurol | 2026 | 41315858 | PubTator, text mining | PubMed |
| Genomic Surveillance Reveals Vaccine-Associated Shifts in Pediatric Invasive Streptococcus pneumoniae in Tunisia. | Vaccines (Basel) | 2025 | 41600943 | PubTator, text mining | PubMed |
| Identification of Cathepsin H and Metabolic Traits as Potential Biomarkers for Lung Cancer by Mendelian Randomization and Single-Cell Transcriptomics. | Adv Genet (Hoboken) | 2025 | 41473685 | PubTator, text mining | PubMed |
| Role of cathepsin in mediating the effect of oral flora on myocardial infarction: A multi-omics and mediation Mendelian randomization study. | Medicine (Baltimore) | 2025 | 41465981 | PubTator, text mining | PubMed |
| Bone Marker Proteins at Baseline and After Insulin-Induced Hypoglycaemia in Type 2 Diabetes. | Int J Mol Sci | 2025 | 41373586 | PubTator, text mining | PubMed |
| Altered Transcriptome Signature in Primary Human Myotubes Exposed to Inclusion Body Myositis Serum: A Pilot Case Comparison of Anti-cN1A Positive and Negative Sera. | Muscles | 2025 | 41283441 | PubTator, text mining | PubMed |
| A Modification to Two-Stage Least Squares With Genetic Applications. | Stat Med | 2025 | 41201239 | PubTator, text mining | PubMed |
| Identification of coagulation-related biomarkers in osteoarthritis and immune infiltration analysis based on bioinformatics. | Hereditas | 2025 | 41146237 | PubTator, text mining | PubMed |
| From plasma proteomics Mendelian randomization to neuropathological validation: The potential role of CTSH-GRN-TMEM106B and TREM2-IL-34 networks of microglia in Alzheimer's disease. | Eur J Pharmacol | 2025 | 41138838 | PubTator, text mining | PubMed |
| MRanalysis: a comprehensive online platform for integrated, multimethod Mendelian randomization and associated post-GWAS analyses. | Gigascience | 2025 | 41124022 | PubTator, text mining | PubMed |
| Causal roles of cathepsins family members in breast cancer subtypes: insights from Mendelian randomization and bioinformatics analysis. | Discov Oncol | 2025 | 41123761 | PubTator, text mining | PubMed |
| IGF2BP2 contributes to thyroid cancer progression by enhancing the stability of m6A-modified CTSH mRNA. | PLoS One | 2025 | 41100504 | PubTator, text mining | PubMed |
| Deciphering the role of cathepsins in digestive system cancers: a Mendelian randomization study. | Discov Oncol | 2025 | 41026370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1512/papers?page=2